Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5596 to 5610 of 8314 results

  1. In adults with common bile duct stones, should laparoscopic cholecystectomy be performed early (within 2 weeks of bile duct clearance), or should it be delayed (until 6 weeks after bile duct clearance)?

    Recommendation ID CG188/4 Question In adults with common bile duct stones, should laparoscopic cholecystectomy be performed early (within

    Research recommendation
    Published
    9 June 2015

  2. Non-metformin-based drug treatment combinations to control blood glucose levels: In adults with type 2 diabetes, what treatment combinations (for example, glucagon‑like peptide‑1 [GLP‑1] mimetics and insulin combination therapy with meglitinides) are most effective when initial drug treatment with non‑metformin monotherapy fails to adequately control blood glucose levels?

    Recommendation ID NG28/02 Question Non-metformin-based drug treatment combinations to control blood glucose levels: In adults with type

    Research recommendation
    Published
    16 December 2021

  3. Indicators and thresholds for referral for cataract surgery:- What is the association between preoperative vision- and health-related quality of life, and postoperative vision-related quality of life, health-related quality of life, and self-reported postoperative improvement?

    Recommendation ID NG77/3 Question Indicators and thresholds for referral for cataract surgery:- What is the association between preoperative

    Research recommendation
    Published
    6 November 2018

  4. Individual versus group CBT for children and young people with social anxiety disorder:- What is the clinical and cost effectiveness of individual and group CBT for children and young people with social anxiety disorder?

    Recommendation ID CG159/4 Question Individual versus group CBT for children and young people with social anxiety disorder:- What is the

    Research recommendation
    Published
    9 June 2015

  5. What is the clinical and cost effectiveness of prednisolone compared with aminosalicylates for the induction of remission for people with moderate ulcerative colitis?

    Recommendation ID NG130/4 Question What is the clinical and cost effectiveness of prednisolone compared with aminosalicylates for the induction

    Research recommendation
    Published
    25 October 2019

  6. What is the clinical and cost effectiveness of prednisolone plus an aminosalicylate compared with beclometasone plus an aminosalicylate for induction of remission for people with moderate ulcerative colitis?

    Recommendation ID NG130/5 Question What is the clinical and cost effectiveness of prednisolone plus an aminosalicylate compared with beclometasone

    Research recommendation
    Published
    25 October 2019

  7. What are the benefits, risks and cost effectiveness of methotrexate, ciclosporin, tacrolimus, adalimumab and infliximab compared with each other and with placebo for induction of remission for people with subacute ulcerative colitis that is refractory to systemic corticosteroids?

    Recommendation ID NG130/6 Question What are the benefits, risks and cost effectiveness of methotrexate, ciclosporin, tacrolimus, adalimumab

    Research recommendation
    Published
    25 October 2019

  8. Further research is recommended on alternative postpartum testing strategies that do not include cord blood typing of all babies born to rhesus-D (D) negative women.

    Recommendation ID DG25/1 Question Further research is recommended on alternative postpartum testing strategies that do not include cord

    Research recommendation
    Published
    10 February 2017

  9. Further research is recommended on clinical outcomes associated with using the ELISA kits (LISA-TRACKER, IDKmonitor and Promonitor) in people whose Crohn's disease is losing response to a TNF-alpha inhibitor. This could be through a prospective study, for local audit, or for submission to a registry. (The IBD Registry is being adapted to receive data on TNF-alpha inhibitor levels and antibodies against TNF-alpha inhibitors).

    Recommendation ID DG22/2 Question Further research is recommended on clinical outcomes associated with using the ELISA kits (LISA-TRACKER

    Research recommendation
    Published
    21 March 2016

  10. Further research is recommended on clinical outcomes associated with using the ELISA kits (LISA-TRACKER, IDKmonitor and Promonitor) to monitor TNF-alpha-inhibitor levels and antibodies to a TNF-alpha inhibitor in people with Crohn's disease whose disease responds to treatment with TNF-alpha inhibitors. This should be evaluated using prospective studies.

    Recommendation ID DG22/3 Question Further research is recommended on clinical outcomes associated with using the ELISA kits (LISA-TRACKER

    Research recommendation
    Published
    21 March 2016

  11. Further research is recommended on how using sex-specific 99th percentile thresholds affects treatment decisions and clinical outcomes for men and women.

    Recommendation ID DG40/2 Question Further research is recommended on how using sex-specific 99th percentile thresholds affects treatment

    Research recommendation
    Published
    26 October 2020

  12. Further research is recommended on patient acceptability of using virtual chromoendoscopy for real-time assessment of diminutive polyps compared with assessment using histopathology

    Recommendation ID DG28/1 Question Further research is recommended on patient acceptability of using virtual chromoendoscopy for real-time

    Research recommendation
    Published
    12 October 2018

  13. Further research is recommended on resource use and clinical effects associated with using the xTAG Gastrointestinal Pathogen Panel, the FilmArray GI Panel and the Faecal Pathogens B assay.

    Recommendation ID DG26/1 Question Further research is recommended on resource use and clinical effects associated with using the xTAG Gastrointestinal

    Research recommendation
    Published
    17 February 2017

  14. Further research is recommended on: The accuracy of EarlyCDT Lung, and the validity of the risk models used to combine EarlyCDT Lung results with the Brock and the Herder risk models. The impact of EarlyCDT Lung on clinical management decisions. A large retrospective audit is recommended to: Understand how patient and nodule characteristics impact on malignancy prevalence and disease progression. Understand current practice regarding clinical management of people with intermediate-risk lung nodules. Determine the clinical consequences of CT surveillance, including the likelihood of disease progression during CT surveillance. Determine the likelihood and impact of unnecessary biopsy or resection of indolent and benign nodules If existing data on these points is limited or not routinely collected, a prospective data collection should be undertaken to obtain it.

    Recommendation ID DG46/01 Question Further research is recommended on: The accuracy of EarlyCDT Lung, and the validity of the risk models

    Research recommendation
    Published
    24 March 2022

  15. Further research is recommended on the diagnostic performance of the TriageTrue high-sensitivity troponin test using samples at point of care.

    Recommendation ID DG40/1 Question Further research is recommended on the diagnostic performance of the TriageTrue high-sensitivity troponin

    Research recommendation
    Published
    26 October 2020